A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors
Clinical trial NCT05086848 · COMPLETED
Trial details
- NCT number
- NCT05086848
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-05
- Primary completion
- 2018-06-06
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.